Literature DB >> 17609263

The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1.

Gisela Heidecker1, Patricia A Lloyd, Ferri Soheilian, Kunio Nagashima, David Derse.   

Abstract

The PPPY motif in the matrix (MA) domain of human T-cell leukemia virus type 1 (HTLV-1) Gag associates with WWP1, a member of the HECT domain containing family of E3 ubiquitin ligases. Mutation of the PPPY motif arrests particle assembly at an early stage and abolishes ubiquitination of MA. Similar effects are seen when Gag is expressed in the presence of a truncated form of WWP1 that lacks the catalytically active HECT domain (C2WW). To understand the role of ubiquitination in budding, we mutated the four lysines in MA to arginines and identified lysine 74 as the unique site of ubiquitination. Virus-like particles produced by the K74R mutant did not contain ubiquitinated MA and showed a fourfold reduction in the release of infectious particles. Furthermore, the K74R mutation rendered assembly hypersensitive to C2WW inhibition; K74R Gag budding was inhibited at significantly lower levels of expression of C2WW compared with wild-type Gag. This finding indicates that the interaction between Gag and WWP1 is required for functions other than Gag ubiquitination. Additionally, we show that the PPPY(-) mutant Gag exerts a strong dominant-negative effect on the budding of wild-type Gag, further supporting the importance of recruitment of WWP1 to achieve particle assembly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609263      PMCID: PMC2045422          DOI: 10.1128/JVI.00642-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Mechanisms of enveloped RNA virus budding.

Authors:  Owen Pornillos; Jennifer E Garrus; Wesley I Sundquist
Journal:  Trends Cell Biol       Date:  2002-12       Impact factor: 20.808

3.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.

Authors:  Dimiter G Demirov; Akira Ono; Jan M Orenstein; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

Authors:  L Naldini; U Blömer; F H Gage; D Trono; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect.

Authors:  Eva Gottwein; Stefanie Jäger; Anja Habermann; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle.

Authors:  B Yuan; X Li; S P Goff
Journal:  EMBO J       Date:  1999-09-01       Impact factor: 11.598

7.  Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.

Authors:  David Derse; Shawn A Hill; Gerald Princler; Patricia Lloyd; Gisela Heidecker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

8.  The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release.

Authors:  Eva Gottwein; Jochen Bodem; Barbara Müller; Ariane Schmechel; Hanswalter Zentgraf; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  The protein network of HIV budding.

Authors:  Uta K von Schwedler; Melissa Stuchell; Barbara Müller; Diane M Ward; Hyo-Young Chung; Eiji Morita; Hubert E Wang; Thaylon Davis; Gong-Ping He; Daniel M Cimbora; Anna Scott; Hans-Georg Kräusslich; Jerry Kaplan; Scott G Morham; Wesley I Sundquist
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

10.  Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4.

Authors:  Joanna Timmins; Guy Schoehn; Sylvie Ricard-Blum; Sandra Scianimanico; Thierry Vernet; Rob W H Ruigrok; Winfried Weissenhorn
Journal:  J Mol Biol       Date:  2003-02-14       Impact factor: 5.469

View more
  26 in total

1.  Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.

Authors:  Jingga Inlora; Vineela Chukkapalli; David Derse; Akira Ono
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  Ubiquitin-dependent virus particle budding without viral protein ubiquitination.

Authors:  Maria Zhadina; Myra O McClure; Marc C Johnson; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-03       Impact factor: 11.205

Review 3.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

4.  A PLPPV sequence in the p8 region of Gag provides late domain function for mouse mammary tumor virus.

Authors:  Lori V Coren; Kunio Nagashima; David E Ott
Journal:  Virology       Date:  2019-07-19       Impact factor: 3.616

5.  The role of ITCH protein in human T-cell leukemia virus type 1 release.

Authors:  Batsukh Dorjbal; David Derse; Patricia Lloyd; Ferri Soheilian; Kunio Nagashima; Gisela Heidecker
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

6.  ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.

Authors:  Ziying Han; Cari A Sagum; Mark T Bedford; Sachdev S Sidhu; Marius Sudol; Ronald N Harty
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

7.  Functional replacement of a retroviral late domain by ubiquitin fusion.

Authors:  Anjali Joshi; Utpal Munshi; Sherimay D Ablan; Kunio Nagashima; Eric O Freed
Journal:  Traffic       Date:  2008-08-09       Impact factor: 6.215

8.  Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication.

Authors:  Olga A Nikolaitchik; Robert J Gorelick; Maria G Leavitt; Vinay K Pathak; Wei-Shau Hu
Journal:  Virology       Date:  2008-03-19       Impact factor: 3.616

Review 9.  Antiviral activity of innate immune protein ISG15.

Authors:  Ronald N Harty; Paula M Pitha; Atsushi Okumura
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

10.  The Mechanism of Budding of Retroviruses From Cell Membranes.

Authors:  Andrew Pincetic; Jonathan Leis
Journal:  Adv Virol       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.